News
Scottish Biotech Innovator Secures Up To £1.1 Million Investment From Scottish Enterprise
Green Bioactives, a leader in the sustainable production of plant-based natural products through its proprietary Plant Cell Culture Technology platform, has secured grant of up to £1,097,016 from Scottish Enterprise. The grant will support an 18-month research and development initiative focused on the production and initial scale-up of natural products that are derived from plant cell culture, which will enable Green Bioactives to supply customers in waiting in the cosmetic and personal care industries.
Scottish biotech company secures £3.4 million
Scottish biotech engineering company uFraction8 has secured £3.4m in new investment, following the completion of a funding round led by Foresight Group.
Based in Falkirk with a fully-owned subsidiary in Poland, uFraction8’s microfiltration technology is designed to optimise cell and biomass production, offering an energy-efficient alternative to traditional methods used in the production of food, feed and bio-based products.
Source: Business Insider
Funding boost for fertility technology
Dyneval, a pioneering agriculture fertility technology company has raised £515,772 in a new funding round, including investment from Lifted Ventures, to advance its groundbreaking product, the Dynescan.
The Dynescan is the first semen analyzer capable of measuring semen quality over time under conditions mimicking the reproductive tract.
Application of new technology to make an affordable anti-parasite vaccine
Scientists at the Moredun Research Institute, in Midlothian Science Zone, and the Pirbright Institute, in Surrey, have been awarded a £1.7 million grant over three years by the Bill & Melinda Gates Foundation to develop a vaccine against a life-threatening parasite of sheep and goats.
How Edinburgh pioneer behind 'holy grail' gene therapy technology raised £3 million
An Edinburgh-based biotech pioneer behind technology described as the “holy grail for emerging gene therapies” has been given a £3 million funding injection.
Concinnity Genetics - co-founded by Jessica Birt and Matthew Dale - has developed novel control mechanisms using a cutting-edge artificial intelligence (AI) platform and its synthetic biology expertise.
Source: The Scotsman
Carbogenics secures funding for overseas expansion
Carbogenics has closed its latest funding round, securing just under £500,000.
The University of Edinburgh spin-out turns difficult-to-recycle secondary-biomass into a product called CreChar. This is a carbon-rich, porous material should help stabilise the performance of anaerobic digestion plants.
Source: Business Insider
Unleashing start-up talent
A package of measures to help entrepreneurs start and grow their businesses will be delivered next year with funding in the draft Scottish Budget 2025/26. As part of £15 million investment, at least £4 million will be invested to expand the number of women entrepreneurs by providing tailored support at the earliest stages of business creation.
New multi-million government funding to make Scotland world-leading start-up hub
The Scottish Government has announced a series of measures to unleash start-up talent and bridge the gender gap in the entrepreneurial sector.
As part of the £15m allocated to the start-up economy in the draft Scottish Budget 2025/26, £4m will be invested in encouraging female entrepreneurs.
Source: Holyrood
What Was Life Like for Innovating UK Businesses in 2024
Innovate UK has released its State of Innovation 2024 survey, drawing on data from over 2,000 UK firms to provide a thorough breakdown of UK businesses’ innovation activities, including their priorities, challenges, and plans for the year ahead.
Source: Digit News
Cytomos secures £5 million for scale-up
Midlothian-based biotechnology company Cytomos has secured £5 million to scale up production of its cell analysis technology.
Cytomos said that the investment will enable it to drive sales of its first commercial product, Celledonia™, built on its cell analysis technology platform, AuraCyt, which is “already generating significant market traction.”